Few biotech executives explain their experimental therapies by comparing them to video games. Nan Ji, president and CEO of PAQ Therapeutics, does so enthusiastically, and by using a 40-year-old game ...
BURLINGTON, Mass., May 7, 2025 /PRNewswire/ -- PAQ Therapeutics, a biotechnology company developing best- and first-in-class KRAS degraders for patients with lethal cancers lacking effective treatment ...
PAQ Therapeutics hopes to break into the emerging field of autophagy, which is essentially the cell's garbage disposal, to complement or compete against the broader protein degradation field. The ...
"We are excited to welcome Dr Andrew Krivoshik to the team, as he brings a wealth of experience in delivering much-needed oncology medicines to patients, in addition to a strong understanding of the ...
Increasing emphasis is being placed on the development of authentic instruments for assessing the competence of health professionals. Patients offer a unique perspective for assessing aspects of ...
PAQ Therapeutics has launched with $30 million in series A financing. The Cambridge, Massachusetts–based start-up aims to design drugs that manipulate autophagy, a complex process sometimes described ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback